09th week of 2020 patent applcation highlights part 10 |
Patent application number | Title | Published |
20200060961 | Skin Care Composition | 2020-02-27 |
20200060962 | SILOXANE COMPOSITION | 2020-02-27 |
20200060963 | SUBLINGUAL THERAPEUTIC SOLUTIONS AND METHODS | 2020-02-27 |
20200060964 | SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS | 2020-02-27 |
20200060965 | Drug Delivery Systems | 2020-02-27 |
20200060966 | METHODS OF TREATING OVERACTIVE BLADDER USING TROSPIUM | 2020-02-27 |
20200060968 | SPECIALLY FORMULATED COMPOSITIONS OF INHALED NINTEDANIB AND NINTEDANIB SALTS | 2020-02-27 |
20200060969 | Methods for Treating Lung Disorders | 2020-02-27 |
20200060970 | EXOSOME PREPARATION FOR TREATING DISEASE AND APPLICATION THEREOF | 2020-02-27 |
20200060971 | DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA | 2020-02-27 |
20200060972 | FORMULATIONS OF POLYINOSINIC ACID AND POLYCYTIDYLIC ACID FOR THE PREVENTION OF UPPER RESPIRATORY TRACT INFECTIONS | 2020-02-27 |
20200060973 | PHARMACEUTICAL COMPOSITION | 2020-02-27 |
20200060974 | High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients | 2020-02-27 |
20200060975 | COMPOSITION FOR DISINTEGRATING TABLETS CONTAINING MICROFIBROUS CELLULOSE AND ACTIVE INGREDIENT | 2020-02-27 |
20200060976 | FORMULATIONS OF ENZALUTAMIDE | 2020-02-27 |
20200060977 | PREPARATION METHOD OF NALTREXONE IMPLANTS | 2020-02-27 |
20200060978 | COMPOSITION FOR CONTROLLED RELEASE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES AND PROCESS FOR ITS PREPARATION | 2020-02-27 |
20200060979 | MEMBRANE LIPID COATED NANOPARTICLES AND METHOD OF USE | 2020-02-27 |
20200060980 | COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF | 2020-02-27 |
20200060981 | CATIONIC NANOPARTICLES FOR ENHANCING INFECTIOUS CAPACITY OF LIVE VIRUSES | 2020-02-27 |
20200060982 | PURIFIED THERAPEUTIC NANOPARTICLES AND PREPARATION METHODS THEREOF | 2020-02-27 |
20200060983 | HYBRID NANOPARTICLES CONTAINING BORON-DOPED GRAPHENE QUANTUM DOTS AND APPLICATIONS THEREOF | 2020-02-27 |
20200060984 | Methods of Delivering An Oral Care Active by Administering Oral Care Articles Comprising A Filament | 2020-02-27 |
20200060985 | Microreservoir system based on polysiloxanes and ambiphilic solvents | 2020-02-27 |
20200060986 | TRANSDERMAL THERAPEUTIC SYSTEM | 2020-02-27 |
20200060987 | PHARMACEUTICAL COMPOSITIONS COMPRISING SEMIFLUORINATED ALKANES FOR THE TREATMENT OF CONTACT LENSE-RELATED CONDITIONS | 2020-02-27 |
20200060988 | APPLICATION OF CLOFOCTOL FOR MANUFACTURING PHARMACEUTICAL PRODUCT FOR TREATING HUMAN NEUROGLIOMA | 2020-02-27 |
20200060989 | QUINIC ACID-MODIFIED NANOPARTICLES AND USES THEREOF | 2020-02-27 |
20200060990 | Compositions for Mitigating Brain Trauma and Methods Thereof | 2020-02-27 |
20200060992 | THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS | 2020-02-27 |
20200060993 | CAROTENOID-CONTAINING COGNITIVE FUNCTION IMPROVING COMPOSITION FOR USE IN EXERCISE THERAPY FOR IMPROVING COGNITIVE FUNCTION | 2020-02-27 |
20200060994 | METHODS OF TREATING PSYCHIATRIC STRESS DISORDERS | 2020-02-27 |
20200060995 | Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity | 2020-02-27 |
20200060996 | VISUAL CYCLE MODULATORS | 2020-02-27 |
20200060998 | MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA AND PATHOGENIC YEAST | 2020-02-27 |
20200060999 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR USE AS A PROMOTER OF SATELLITE CELLS SELF-RENEWAL AND/OR DIFFERENTIATION | 2020-02-27 |
20200061000 | CHARACTERIZATION OF THE ORAL MICROBIOME FOR THE NON-INVASIVE DIAGNOSIS OF BARRETT'S ESOPHAGUS | 2020-02-27 |
20200061001 | METHOD FOR ALLEVIATING KERATOCONJUNCTIVITIS SICCA | 2020-02-27 |
20200061002 | TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF | 2020-02-27 |
20200061003 | ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME | 2020-02-27 |
20200061004 | COMPOSITIONS AND METHODS FOR DELIVERING CANNABIDIOL AND KETONE BODIES | 2020-02-27 |
20200061005 | METHOD FOR PREVENTING OR TREATING AUTISM SPECTRUM DISORDERS BY BENZOIC ACID SALT | 2020-02-27 |
20200061006 | Treatment of intrahepatic cholestatic diseases | 2020-02-27 |
20200061007 | CANCER STEM CELL PROLIFERATION INHIBITOR | 2020-02-27 |
20200061008 | METHOD OF TREATMENT FOR REDUCING PAIN SENSITIZATION | 2020-02-27 |
20200061009 | Health functional food for reducing and preventing capillary hemorrhage | 2020-02-27 |
20200061010 | COMPOSITION FOR IMPROVING BRAIN FUNCTION | 2020-02-27 |
20200061011 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | 2020-02-27 |
20200061012 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2020-02-27 |
20200061013 | NUTRITIONAL COMPOSITION FOR USE IN THERAPY OF PATIENTS WITH SARCOPENIA AND/OR FRAILTY OR PRE-SARCOPENIC AND/OR PRE-FRAIL PATIENTS | 2020-02-27 |
20200061014 | A PHARMACEUTICAL COMPOSITION COMPRISING RACECADOTRL AND PROCESS FOR PREPARING THE SAME | 2020-02-27 |
20200061015 | Lipase Degradation Resistant Surfactants for Use in Large Molecule Therapeutic Formulations | 2020-02-27 |
20200061016 | ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE | 2020-02-27 |
20200061017 | METHODS FOR TREATING OR PREVENTING FATIGUE | 2020-02-27 |
20200061018 | METHODS AND COMPOSITIONS FOR TREATING PARKINSON'S DISEASE | 2020-02-27 |
20200061019 | DRUG DELIVERY SYSTEM FOR TREATMENT OF CANCER | 2020-02-27 |
20200061020 | FORMULATIONS AND COMPOSITIONS OF DOCETAXEL | 2020-02-27 |
20200061021 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | 2020-02-27 |
20200061022 | IMMEDIATE RELEASE FORMULATIONS OF CANNABINOIDS | 2020-02-27 |
20200061023 | COMPOSITIONS AND METHODS FOR DELIVERING TETRAHYDROCANNABINOL AND KETONE BODIES | 2020-02-27 |
20200061024 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | 2020-02-27 |
20200061025 | ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE AND PREPARATION METHOD THEREOF | 2020-02-27 |
20200061026 | METHODS AND COMPOSITIONS FOR PREVENTING VECTOR-BORNE DISEASE TRANSMISSION | 2020-02-27 |
20200061027 | PHARMACOLOGICAL RESTORATION OF EPITHELIAL OR ENDOTHELIAL BARRIER INTEGRITY BY AGENTS BLOCKING EPAC/RAP1 SIGNALING | 2020-02-27 |
20200061028 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | 2020-02-27 |
20200061029 | Glaucocalyxin A Derivative, Pharmaceutically Acceptable Salt Thereof, Or Pharmaceutical Composition Thereof And Uses Thereof In Preparation Of Drugs For Treating Psoriasis | 2020-02-27 |
20200061030 | DUAL INHIBITORS OF VISTA AND PD-1 PATHWAYS | 2020-02-27 |
20200061031 | METHOD FOR TREATING EGFR-TKI-RESISTANT NON-SMALL CELL LUNG CANCER BY ADMINISTRATION OF ANTI-HER3 ANTIBODY-DRUG CONJUGATE | 2020-02-27 |
20200061032 | METHODS OF TREATING HEPATIC ENCEPHALOPATHY | 2020-02-27 |
20200061033 | NOVEL ISOINDOLINE DERIVATIVE, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2020-02-27 |
20200061034 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLIPIDEM | 2020-02-27 |
20200061035 | LONG-ACTING POLYMERIC DELIVERY SYSTEMS COMPRISING OLANZAPINE AND A 5-HT3 RECEPTOR ANTAGONIST | 2020-02-27 |
20200061036 | ACECLIDINE ISOMERS AND SCALEMIC MIXTURES THEREOF FOR THE TREATMENT OF PRESBYOPIA | 2020-02-27 |
20200061037 | COMPOUNDS THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE | 2020-02-27 |
20200061038 | THERAPEUTIC AGENT FOR FIBROSIS AND INHIBITOR OF NUCLEAR TRANSLOCATION OF PHOSPHORYLATED SMAD | 2020-02-27 |
20200061039 | PYRIDINONE COMPOUND AND USE THEREOF | 2020-02-27 |
20200061040 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | 2020-02-27 |
20200061041 | PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES | 2020-02-27 |
20200061042 | SOLID FORMS OF AN ASK1 INHIBITOR | 2020-02-27 |
20200061043 | Pharmaceutical Salts Of Isomyosmine And Pharmaceutical Compositions Containing Same | 2020-02-27 |
20200061044 | PHACETOPERANE FOR TREATING OF ATTENTION DEFICIT HYPERACTIVITY DISORDER | 2020-02-27 |
20200061045 | PIMAVANSERIN FOR TREATING IMPULSE CONTROL DISORDER | 2020-02-27 |
20200061046 | USE OF ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISORDERS, INCREASE NEUROPLASTICITY, AND PROMOTE NEUROPROTECTION | 2020-02-27 |
20200061047 | NEW USE OF RIFAMYCIN-QUINOLIZIDONE DUAL-ACTION MOLECULE | 2020-02-27 |
20200061048 | METHOD FOR TREATING OSTEOPOROSIS, OSTEOPENIA OR LOW BONE MINERAL DENSITY | 2020-02-27 |
20200061049 | METHOD FOR PREVENTING OR TREATING TUMOR DISEASES WITH A COMBINATION OF TYROSINE KINASE INHIBITOR AND CDK4/6 INHIBITOR | 2020-02-27 |
20200061050 | KINASE INHIBITORS AND METHODS OF USE THEREOF | 2020-02-27 |
20200061051 | METHODS OF ENHANCING IMMUNE RESPONSE | 2020-02-27 |
20200061052 | MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE | 2020-02-27 |
20200061053 | PHARMACEUTICAL COMPOSITION AND METHOD FOR ACUTE ON CHRONIC LIVER FAILURE AND RELATED LIVER DISEASES | 2020-02-27 |
20200061054 | USE OF DIANHYDROGALACTITOL OR ANALOGS AND DERIVATIVES IN COMBINATION WITH A P53 MODULATOR OR A PARP INHIBITOR | 2020-02-27 |
20200061055 | COMPOUNDS AND METHODS FOR TREATING CANCER | 2020-02-27 |
20200061056 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS | 2020-02-27 |
20200061057 | CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD | 2020-02-27 |
20200061058 | PHARMACEUTICAL FORMULATION CONTAINING TADALAFIL | 2020-02-27 |
20200061059 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | 2020-02-27 |
20200061060 | METHODS FOR TREATING LYMPHOMA | 2020-02-27 |
20200061061 | COMBINATIONS OF A 4-PYRIMIDINESULFAMIDE DERIVATIVE WITH ACTIVE INGREDIENTS FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES | 2020-02-27 |
20200061062 | INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2020-02-27 |
20200061063 | BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF | 2020-02-27 |